#Novonordiskas

For some experts, the outbreak is raising broader concerns about how equipped the U.S. is to respond to future infectious disease threats.

Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity injection Wegovy.

Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.

Taiwan's Taiex and South Korea's Kospi stock markets have been seeing record breaking rallies. The stunning surge leaves experts wondering if this growth hinges largely on a few AI-linked semiconductor giants.

New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.

From Google News - World: Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals - CNBC

Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.

Early signs from the launch of Novo Nordisk's Wegovy pill and Eli Lilly & Co.'s Foundayo are making investors rethink the opportunity for GLP-1 pills.

Early signs from the launch of Novo Nordisk's Wegovy pill and Eli Lilly & Co.'s Foundayo are making investors rethink the opportunity for GLP-1 pills.

Obesity assets represent about 25% of total forecast sales of the late-stage pipeline, while oncology's share has slipped to 20%, Deloitte found.

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines ​unless they appear on the FDA's ⁠drug shortage ⁠list.

Eli Lilly's weight loss pill launch has been closely watched after the successful start of Novo Nordisk's Wegovy pill.

From CNBC: Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket